Cancer cachexia results in an increase in TNF-α receptor gene expression in both skeletal muscle and adipose tissue

International Journal of Oncology

Volumn 27, Issue 3, 2005, Pages 855-860

  Figueras, Maite ^a   Busquets, Sílvia ^a   Carbó, Neus ^a   Almendro, Vanessa ^a   Argilés, Josep M ^a   López Soriano, Francisco J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cancer cachexia; Cytokines; Skeletal muscle; TNF a; TNFRs

Indexed keywords

MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADIPOSE TISSUE; ANIMAL; ARTICLE; BIOLOGICAL MODEL; CACHEXIA; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; MALE; METABOLISM; PATHOPHYSIOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; TIME; TUMOR CELL LINE; WESTERN BLOTTING; WISTAR RAT;

ADIPOSE TISSUE; ANIMALS; BLOTTING, WESTERN; CACHEXIA; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; RATS; RATS, WISTAR; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 24344448272     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Lawson DH, Richmond A, Nixon DW and Rudman D: Metabolic approaches to cancer cachexia. Annu Rev Nutr 2: 277-301, 1982.
2. Argilés JM, Garcia-Martinez C, Llovera M and Löpez-Soriano FJ: The role of cytokines in muscle wasting: its relation with cancer cachexia. Med Res Rev 12: 637-652, 1992.
3. Oliff A, Defeo-Jones D, Boyer M, Martinez, Kiefer D, Vuocolo G, Wolfe A and Socher SH: Tumors secreting human TNF/cachectin induce cachexia in mice. Cell 50: 555-563, 1987.
4. Tracey KJ, Wei H, Manogue KR, Fong Y, Hesse DG, Nguyen HT, Kuo GC, Beutler B, Cotran RS and Cerami A: Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med 167: 1211-1227, 1988.
5. Argilés JM and Azcon-Bieto J: The metabolic environment of cancer. Mol Cell Biochem 81:3-17, 1988.
6. Argilés JM and Löpez-Soriano FJ: The role of cytokines in cancer cachexia. Med Res Rev 19: 223-248, 1999.
7. Costelli P, Carbö N, Tessitore L, Bagby GJ, Löpez-Soriano FJ, Argilés JM and Baccino FM: Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest 92: 2783-2789, 1993.
8. Carbö N, Costelli P, Tessitore L, Bagby GJ, Löpez-Soriano FJ, Baccino FM and Argilés JM: Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model. Clin Sci 87: 349-355, 1994.
9. Hohmann HP, Remy R, Brockhaus M and van Loon AP: Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha). J Biol Chem 264: 14927-14934, 1989.
10. Fiers W, Beyaert R, Boone E, Cornelis S, Declercq W, Decoster E, Denecker G, Depuydt B, De Valck D, De Wilde G, Goossens V, Grooten J, Haegeman G, Heyninck K, Penning L, Plaisance S, Vancompernolle K, van Criekinge W, Vandenabeele P, van den Berghe W, van de Craen M, Vandevoorde V and Vercammen D: TNF-induced intracellular signaling leading to gene induction or to cytotoxicity by necrosis or by apoptosis. J Inflamm 47: 67-75, 1995-96.
11. Llovera M, Garcia-Martinez C, Löpez-Soriano J, Carbö N, Agell N, López-Soriano FJ and Argilés JM: Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout mice. Mol Cell Endocrinol 142: 183-189, 1998.
12. Tessitore L, Bonelli G and Baccino FM: Early development of protein metabolic perturbations in the liver and skeletal muscle of tumour-bearing rats. A model system for cancer cachexia. Biochem J 241: 153-159, 1987.
13. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 56-59, 1987.
14. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
15. Aggarwal BB and Natarajan K: Tumor necrosis factors: developments during the last decade. Eur Cytokine Netw 7: 93-124,1996.
16. Llovera M, Löpez-Soriano FJ and Argilés JM: Chronic tumour necrosis factor-alpha treatment modifies protein turnover in rat tissues. Biochem Mol Biol Int 30: 29-36, 1993.
17. Garcia-Martinez C, Agell N, Llovera M, Löpez-Soriano FJ and Argilés JM: Tumour necrosis factor-alpha increases the ubiquitinization of rat skeletal muscle proteins. FEBS Lett 323: 211-214,1993.
18. Garcia-Martinez C, Llovera M, Agell N, Löpez-Soriano FJ and Argilés JM: Ubiquitin gene expression in skeletal muscle is increased during sepsis: involvement of TNF-alpha but not IL-1. Biochem Biophys Res Comraun 217: 839-844, 1995.
19. Llovera M, Garcia-Martinez C, Agell N, Lopez-Soriano FJ and Argilés JM: TNF can directly induce the expression of ubiquitindependent proteolytic system in rat soleus muscles. Biochem Biophys Res Commun 230: 238-241, 1997.
20. Ebisui C, Tsujinaka T, Morimoto T, Fujita J, Ogawa A, Ishidoh K, Kominami E, Tanaka K and Monden M: Changes of proteasomes and cathepsins activities and their expression during differentiation of C2C12 myoblasts. J Biochem 117: 1088-1094, 1995.
21. Alvarez B, Quinn LS, Busquets S, Quiles MT, Löpez-Soriano FJ and Argilés JM: Tumor necrosis factor-alpha exerts interleukin-6- dependent and -independent effects on cultured skeletal muscle cells. Biochim Biophys Acta 1542: 66-72, 2002.
22. Argilés JM, Alvarez B, Carbö N, Busquets S, van Royen M and Löpez-Soriano FJ: The divergent effects of tumour necrosis factor-alpha on skeletal muscle: implications in wasting. Eur Cytokine Netw 11: 552-559, 2000.
23. Alvarez B, Quinn LS, Busquets S, Löpez-Soriano FJ and Argilés JM: Direct effects of tumor necrosis factor alpha (TNF-alpha) on murine skeletal muscle cell lines. Bimodal effects on protein metabolism. Eur Cytokine Netw 12: 399-410, 2001.
24. Zhang Y, Pilon G, Marette A and Baracos VE: Cytokines and endotoxin induce cytokine receptors in skeletal muscle. Am J Physiol Endocrinol Metab 279: 196-205, 2000.
25. Noguchi Y, Yoshikawa T, Marat D, Doi C, Makino T, Fukuzawa K, Tsuburaya A, Satoh S, Ito T and Mitsuse S: Insulin resistance in cancer patients is associated with enhanced tumor necrosis factor-alpha expression in skeletal muscle. Biochem Biophys Res Commun 253: 887-892, 1998.
26. Alvarez B, Quinn LS, Busquets S, López-Soriano FJ and Argilés JM: TNF-alpha modulates cytokine and cytokine receptors in C2C12 myotubes. Cancer Lett 175: 181-185, 2002.
27. Carbö N, Busquets S, van Royen M, Alvarez B, López-Soriano FJ and Argilés JM: TNF-alpha is involved in activating DNA fragmentation in skeletal muscle. Br J Cancer 86: 1012-1016, 2002.
28. Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL, Glembotski CC, Quintana PJ and Sabbadini RA: Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 98: 854-865,1996.
29. Madge LA and Pober JS: TNF signaling in vascular endothelial cells. Exp Mol Pathol 70: 317-325, 2001.